1
|
Asemi R, Mafi A, Sharifi M, Homayoonfal M, Davoodvandi A, Asemi Z. Modulation of Long Non-coding RNAs and MicroRNAs by Quercetin as a Potential Therapeutical Approach in Cancer: A Comprehensive Review. Curr Med Chem 2023; 31:CMC-EPUB-135370. [PMID: 37855340 DOI: 10.2174/0109298673256601231009054714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Revised: 06/19/2023] [Accepted: 09/14/2023] [Indexed: 10/20/2023]
Abstract
Cancer can take years to develop, both at its beginning and during its development. All typical epithelial cancers have a long latency period, sometimes 20 years or more, and if they are clinically detected, distinct genes may include infinite mutations. Long non-coding RNAs (LncRNAs) are a subset of RNAs that regulate many biological processes, including RNA processing, epigenetic control, and signal transduction. Current studies show that lncRNAs, which are dysregulated in cancer, play a significant function in the growth and spread of the illness. LncRNAs have been connected to the overexpression of specific proteins that function in tumors' spread and growth. Moreover, through translational inhibition, microRNAs (miRNAs) regulates gene expression sequence specifically. Apart from that, non-coding RNAs known as miRNAs, with a length of around 22 nucleotides, controls gene expressions in a sequence-specific way either by preventing translation or degrading messenger RNA (mRNA). Quercetin appears to have a significant role in altering miRNA and lncRNA expression, which is linked to variations in the production of oncogenes, tumor suppressors, and proteins produced from cancer. Quercetin may change the earliest epigenetic modifications related to cancer prevention in addition to its usual antioxidant or anti-inflammatory effects. It would be beneficial to have more in-depth information on how Quercetin modulates miRNAs and lncRNAs to use it as a cancer therapeutic strategy. Here, we go through what is known about Quercetin's potential to modulate miRNAs and lncRNAs in various malignancies.
Collapse
Affiliation(s)
- Reza Asemi
- Department of Internal Medicine, School of Medicine, Cancer Prevention Research Center, Seyyed Al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Ali Mafi
- Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Mehran Sharifi
- Department of Internal Medicine, School of Medicine, Cancer Prevention Research Center, Seyyed Al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Mina Homayoonfal
- Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R. Iran
| | - Amirhossein Davoodvandi
- Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran
| | - Zatollah Asemi
- Kashan University of Medical Sciences Nutrition K?sh?n Iran
| |
Collapse
|
2
|
Fitzner J, Qasmieh S, Mounts AW, Alexander B, Besselaar T, Briand S, Brown C, Clark S, Dueger E, Gross D, Hauge S, Hirve S, Jorgensen P, Katz MA, Mafi A, Malik M, McCarron M, Meerhoff T, Mori Y, Mott J, Olivera MTDC, Ortiz JR, Palekar R, Rebelo-de-Andrade H, Soetens L, Yahaya AA, Zhang W, Vandemaele K. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ 2017; 96:122-128. [PMID: 29403115 PMCID: PMC5791775 DOI: 10.2471/blt.17.194514] [Citation(s) in RCA: 171] [Impact Index Per Article: 24.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2017] [Revised: 10/30/2017] [Accepted: 10/30/2017] [Indexed: 12/24/2022] Open
Abstract
The formulation of accurate clinical case definitions is an integral part of an effective process of public health surveillance. Although such definitions should, ideally, be based on a standardized and fixed collection of defining criteria, they often require revision to reflect new knowledge of the condition involved and improvements in diagnostic testing. Optimal case definitions also need to have a balance of sensitivity and specificity that reflects their intended use. After the 2009-2010 H1N1 influenza pandemic, the World Health Organization (WHO) initiated a technical consultation on global influenza surveillance. This prompted improvements in the sensitivity and specificity of the case definition for influenza - i.e. a respiratory disease that lacks uniquely defining symptomology. The revision process not only modified the definition of influenza-like illness, to include a simplified list of the criteria shown to be most predictive of influenza infection, but also clarified the language used for the definition, to enhance interpretability. To capture severe cases of influenza that required hospitalization, a new case definition was also developed for severe acute respiratory infection in all age groups. The new definitions have been found to capture more cases without compromising specificity. Despite the challenge still posed in the clinical separation of influenza from other respiratory infections, the global use of the new WHO case definitions should help determine global trends in the characteristics and transmission of influenza viruses and the associated disease burden.
Collapse
Affiliation(s)
- Julia Fitzner
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Saba Qasmieh
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Anthony Wayne Mounts
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Burmaa Alexander
- National Centre for Communicable Diseases, Ulaanbataar, Mongolia
| | - Terry Besselaar
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Sylvie Briand
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Caroline Brown
- Regional Office for Europe, World Health Organization, Copenhagen, Denmark
| | - Seth Clark
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Erica Dueger
- Western Pacific Regional Office, World Health Organization, Manila, Philippines
| | - Diane Gross
- Regional Office for Europe, World Health Organization, Copenhagen, Denmark
| | - Siri Hauge
- Department of Infectious Disease Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
| | - Siddhivinayak Hirve
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Pernille Jorgensen
- Regional Office for Europe, World Health Organization, Copenhagen, Denmark
| | - Mark A Katz
- Centers for Disease Control and Prevention, Atlanta, United States of America (USA)
| | - Ali Mafi
- Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt
| | - Mamunur Malik
- Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt
| | - Margaret McCarron
- Centers for Disease Control and Prevention, Atlanta, United States of America (USA)
| | - Tamara Meerhoff
- Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, Netherlands
| | - Yuichiro Mori
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Joshua Mott
- United States Centers for Disease Control and Prevention Kenya Office, Nairobi, Kenya
| | | | - Justin R Ortiz
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Rakhee Palekar
- Pan American Health Organization, World Health Organization, Washington, USA
| | | | - Loes Soetens
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
| | - Ali Ahmed Yahaya
- Regional Office for Africa, World Health Organization, Brazzaville, Congo
| | - Wenqing Zhang
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| | - Katelijn Vandemaele
- Infectious Hazard Management, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland
| |
Collapse
|
5
|
Mounts A, De La Rocque S, Fitzner J, Garcia E, Thomas HL, Brown D, Schuster H, Vandemaele K, Esmat H, Eremin S, Mafi A. The early response to a novel coronavirus in the Middle East. East Mediterr Health J 2013; 19 Suppl 1:S19-S25. [PMID: 23888791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The detection of a novel coronavirus in patients from the Arabian Peninsula in late 2012 raised serious concerns of a possible international outbreak. Ministries of health of the three affected countries invited missions from the World Health Organization to participate in a review of data and capacity to detect and respond to further cases. Recommendations were made for investigations to answer critical questions about human-to-human transmission and the geographic extent of the virus. Additional recommendations were made to improve surveillance capacity by acquiring the capacity to test for the virus and enhance syndromic surveillance. Available evidence continues to suggest an unknown animal reservoir for the virus with sporadic zoonotic transmission the primary epidemiological pattern of transmission. Human-to-human transmission, while it can occur, does not appear to be sustained in the community.
Collapse
Affiliation(s)
- A Mounts
- Global Infuenza Programme, World Health Organization, Geneva, Switzerland.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Li L, Schülzgen A, Temyanko VL, Li H, Sabet S, Morrell MM, Mafi A, Moloney JV, Peyghambarian N. Investigation of modal properties of microstructured optical fibers with large depressed-index cores. Opt Lett 2005; 30:3275-7. [PMID: 16389803 DOI: 10.1364/ol.30.003275] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
We present what is, to the best of our knowledge, the first systematic study on how negative core-cladding index difference influences microstructured optical fiber's modal behavior. Single-mode lasing has been realized for short-length cladding-pumped phosphate glass microstructured fibers with large depressed-index Er(3+)-Yb(3+)-codoped cores.
Collapse
Affiliation(s)
- L Li
- College of Optical Sciences, The University of Arizona, Tucson, Arizona 85721, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Li L, Schülzgen A, Temyanko VL, Qiu T, Morrell MM, Wang Q, Mafi A, Moloney JV, Peyghambarian N. Short-length microstructured phosphate glass fiber lasers with large mode areas. Opt Lett 2005; 30:1141-3. [PMID: 15943293 DOI: 10.1364/ol.30.001141] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
We report fabrication and testing of the first phosphate glass microstructured fiber lasers with large Er-Yb-codoped cores. For an 11-cm-long cladding-pumped fiber laser, more than 3 W of continuous wave output power is demonstrated, and near single-mode beam quality is obtained for an active core area larger than 400 microm2.
Collapse
Affiliation(s)
- L Li
- Optical Sciences Center, University of Arizona, Tucson, Arizona 85721, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Li L, Li H, Qiu T, Temyanko VL, Morrell MM, Schülzgen A, Mafi A, Moloney JV, Peyghambarian N. 3-Dimensional thermal analysis and active cooling of short-length high-power fiber lasers. Opt Express 2005; 13:3420-3428. [PMID: 19495244 DOI: 10.1364/opex.13.003420] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
A fully 3-dimensional finite element model has been developed that simulates the internal temperature distribution of short-length high-power fiber lasers. We have validated the numerical model by building a short, cladding-pumped, Er-Yb-codoped fiber laser and measuring the core temperature during laser operation. A dual-end-pumped, actively cooled, fiber laser has generated >11 W CW output power at 1535 nm from only 11.9 cm of active fiber. Simulations indicate power-scaling possibilities with improved fiber and cooling designs.
Collapse
|
9
|
Abstract
The aim of this study was to evaluate the effect of sperm chromatin anomalies on fertilization outcome post-intracytoplasmic sperm injection (ICSI). Therefore, along with semen parameters, Chromomycin A3 (CMA3) staining for protamine deficiency, aniline blue staining for excessive histones, SDS for sperm chromatin stability and SDS + EDTA for the ability of sperm to undergo decondensation were carried out on 55 semen samples from patients referred to the Isfahan Fertility and Infertility Center for ICSI. The results showed that among the aforementioned tests and semen parameters only CMA3 showed a significant correlation with fertilization outcome post-ICSI. Patients were also grouped according to CMA3 level of <30% or >30% or fertilization rate of <50% or >50%. The results show that the mean percentage fertilization and mean percentage of CMA3 positivity is different in both groups, respectively. The area under receiver operator characteristics curve shows that CMA3 is a highly sensitive and specific test for prediction of fertilization outcome post-ICSI. In conclusion, that sperm protamine deficiency has profound effect on fertilization failure in ICSI.
Collapse
Affiliation(s)
- S Razavi
- Department of Anatomy, Isfahan University of Medical Sciences, Isfahan, Iran
| | | | | | | | | |
Collapse
|